The treatment of recurrent ovarian carcinoma: balancing patient desires, therapeutic benefit, cost containment and quality of life

Authors
Bomalaski, JJ
Citation
Jj. Bomalaski, The treatment of recurrent ovarian carcinoma: balancing patient desires, therapeutic benefit, cost containment and quality of life, CUR OP OBST, 11(1), 1999, pp. 11-15
Citations number
37
Categorie Soggetti
Reproductive Medicine
Journal title
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY
ISSN journal
1040872X → ACNP
Volume
11
Issue
1
Year of publication
1999
Pages
11 - 15
Database
ISI
SICI code
1040-872X(199902)11:1<11:TTOROC>2.0.ZU;2-K
Abstract
Despite an increasing number of studies utilizing various agents and protoc ols, the disease free interval and survival rates in patients with recurren t ovarian cancer are usually measured in months instead of years. The optim al therapy strategy should be determined using informed decisions based on realistic treatment outcomes, quality of life issues, and cost containment. Curr Opin Obstet Gynecol 11:11-15. (C) 1999 Lippincott Williams & Wilkins.